In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

HTG Molecular Diagnostics, Inc.. Trade Record

NASDAQ:HTGM HTG Molecular Diagnostics, Inc. stock gains 62.66% Exit Jan 17, 2018 a Trade Record by priceseries

Trade Chart
Trade Chart HTGM Dec 21, 2017, priceSeries
About HTG Molecular Diagnostics, Inc.

HTG Molecular Diagnostics, Inc. develops and markets technology platforms that facilitate the routine use of complex molecular profiling. The company's HTG Edge and HTG EdgeSeq platforms consist of instrumentation, consumables, and software analytics that are used in molecular profiling applications, including tumor profiling, biomarker development and prospectively, and molecular diagnostic testing. The company's platforms automate the molecular profiling of genes and gene activity using its nuclease protection chemistry on various biological samples. It provides molecular profiling panels targeting late stage drug development programs with potential breakthrough therapies, such as immuno-oncology. HTG Molecular Diagnostics, Inc. distributes its instruments and consumables directly in the United States and Europe; and through distributors or sales agents in parts of Europe and internationally. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.

Trade Information
Trade Type
LONG
ReliabilityScore™
87.10
Entry Date
Dec 21, 2017
Entry Price
1.90
Sell Date
Jan 17, 2018
Sell Price
3.09
Net Gain
62.66%
Hold Time
16 Trading Days